Luminal-Type Breast Cancer: Correlation of Apparent Diffusion Coefficients with the Ki-67 Labeling Index

被引:105
作者
Mori, Naoko [1 ]
Ota, Hideki [1 ]
Mugikura, Shunji [1 ]
Takasawa, Chiaki [1 ]
Ishida, Takanori [2 ]
Watanabe, Gou [2 ]
Tada, Hiroshi [2 ]
Watanabe, Mika [3 ]
Takase, Kei [1 ]
Takahashi, Shoki [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 9808574, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
INTERNATIONAL EXPERT CONSENSUS; CONTRAST-ENHANCED MRI; CARCINOMA IN-SITU; PROGNOSTIC-FACTORS; POSTMENOPAUSAL WOMEN; DUCTAL CARCINOMA; PATHOLOGICAL FINDINGS; PREDICTIVE-VALUE; PRIMARY THERAPY; WEIGHTED MRI;
D O I
10.1148/radiol.14140283
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the correlation between apparent diffusion coefficient (ADC) values and the Ki-67 labeling index for luminal- type (estrogen receptor-positive) breast cancer not otherwise specified (NOS) diagnosed by means of biopsy. Materials and Methods: The institutional review board approved this retrospective study, and the requirement for informed consent was waived. Between December 2009 and December 2012, 86 patients with 86 lesions with luminal-type invasive breast cancer NOS underwent magnetic resonance imaging, including dynamic contrast material-enhanced imaging and diffusion-weighted imaging with b values of 0 and 1000 sec/mm(2). Conventional measurement of the minimum and mean ADCs by placing regions of interest and histogram analysis of pixel-based ADC data of the entire tumor were performed by two observers independently and correlated with the Ki-67 labeling index of surgical specimens. Results: For the interobserver reliability, interclass correlation coefficients for all parameters with the exception of the minimum ADC exceeded 0.8, indicating almost perfect agreement. The minimum ADC and mean ADC and the 25th, 50th, and 75th percentiles of the histograms showed negative correlations with the Ki-67 labeling index (r = -0.49, -0.55, -0.54, -0.53, and -0.48, respectively). Receiver operating characteristic curve analysis for the differential diagnosis between the high-proliferation (Ki67. 14; n = 44) and low-proliferation (Ki-67, 14; n = 42) groups revealed that the most effective threshold for the mean ADC was lower than 1097 x 10(-6) mm(2)/sec, with sensitivity and specificity of 82% and 71%, respectively. The area under the receiver operating characteristic curve (AUC) was 0.81 for the mean ADC. There were no significant differences in the AUC among the parameters. Conclusion: Considering convenience for routine practice, the authors suggest that the mean ADC of the conventional method would be practical to use for estimating the Ki-67 labeling index.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 36 条
[1]  
[Anonymous], 2003, BREAST IM REP DAT SY
[2]   Diffusion-weighted MR for Differentiation of Breast Lesions at 3.0 T: How Does Selection of Diffusion Protocols Affect Diagnosis? [J].
Bogner, Wolfgang ;
Gruber, Stephan ;
Pinker, Katja ;
Grabner, Guenther ;
Stadlbauer, Andreas ;
Weber, Michael ;
Moser, Ewald ;
Helbich, Thomas H. ;
Trattnig, Siegfried .
RADIOLOGY, 2009, 253 (02) :341-351
[3]   Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer [J].
Cheang, Maggie C. U. ;
Chia, Stephen K. ;
Voduc, David ;
Gao, Dongxia ;
Leung, Samuel ;
Snider, Jacqueline ;
Watson, Mark ;
Davies, Sherri ;
Bernard, Philip S. ;
Parker, Joel S. ;
Perou, Charles M. ;
Ellis, Matthew J. ;
Nielsen, Torsten O. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10) :736-750
[4]   Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer [J].
Choi, S. Y. ;
Chang, Y-W ;
Park, H. J. ;
Kim, H. J. ;
Hong, S. S. ;
Seo, D. Y. .
BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1016) :E474-E479
[5]   Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy [J].
Colleoni, M. ;
Viale, G. ;
Zahrieh, D. ;
Bottiglieri, L. ;
Gelber, R. D. ;
Veronesi, P. ;
Balduzzi, A. ;
Torrisi, R. ;
Luini, A. ;
Intra, M. ;
Dellapasqua, S. ;
Cardillo, A. ;
Ghisini, R. ;
Peruzzotti, G. ;
Goldhirsch, A. .
ANNALS OF ONCOLOGY, 2008, 19 (03) :465-472
[6]   Neoadjuvant therapy for ER-positive breast cancers [J].
Colleoni, M. ;
Montagna, E. .
ANNALS OF ONCOLOGY, 2012, 23 :243-248
[7]   Multimodality Imaging of Triple Receptor-Negative Tumors With Mammography, Ultrasound, and MRI [J].
Dogan, Basak E. ;
Gonzalez-Angulo, Ana Maria ;
Gilcrease, Michael ;
Dryden, Mark J. ;
Yang, Wei Tse .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (04) :1160-1166
[8]   Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group [J].
Dowsett, Mitch ;
Nielsen, Torsten O. ;
A'Hern, Roger ;
Bartlett, John ;
Coombes, R. Charles ;
Cuzick, Jack ;
Ellis, Matthew ;
Henry, N. Lynn ;
Hugh, Judith C. ;
Lively, Tracy ;
McShane, Lisa ;
Paik, Soon ;
Penault-Llorca, Frederique ;
Prudkin, Ljudmila ;
Regan, Meredith ;
Salter, Janine ;
Sotiriou, Christos ;
Smith, Ian E. ;
Viale, Giuseppe ;
Zujewski, Jo Anne ;
Hayes, Daniel F. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22) :1656-1664
[9]   Diffusion-weighted Imaging Improves the Diagnostic Accuracy of Conventional 3.0-T Breast MR Imaging [J].
El Khouli, Riham H. ;
Jacobs, Michael A. ;
Mezban, Sarah D. ;
Huang, Peng ;
Kamel, Ihab R. ;
Macura, Katarzyna J. ;
Bluemke, David A. .
RADIOLOGY, 2010, 256 (01) :64-73
[10]   Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype-ACOSOG Z1031 [J].
Ellis, Matthew J. ;
Suman, Vera J. ;
Hoog, Jeremy ;
Lin, Li ;
Snider, Jacqueline ;
Prat, Aleix ;
Parker, Joel S. ;
Luo, Jingqin ;
DeSchryver, Katherine ;
Allred, D. Craig ;
Esserman, Laura J. ;
Unzeitig, Gary W. ;
Margenthaler, Julie ;
Babiera, Gildy V. ;
Marcom, P. Kelly ;
Guenther, Joseph M. ;
Watson, Mark A. ;
Leitch, Marilyn ;
Hunt, Kelly ;
Olson, John A. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (17) :2342-2349